Your browser doesn't support javascript.
loading
Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.
Klapsa, Dimitra; Wilton, Thomas; Zealand, Andrew; Bujaki, Erika; Saxentoff, Eugene; Troman, Catherine; Shaw, Alexander G; Tedcastle, Alison; Majumdar, Manasi; Mate, Ryan; Akello, Joyce O; Huseynov, Shahin; Zeb, Ali; Zambon, Maria; Bell, Anita; Hagan, José; Wade, Matthew J; Ramsay, Mary; Grassly, Nicholas C; Saliba, Vanessa; Martin, Javier.
Afiliación
  • Klapsa D; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Wilton T; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Zealand A; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK.
  • Bujaki E; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Saxentoff E; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark.
  • Troman C; Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
  • Shaw AG; Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
  • Tedcastle A; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Majumdar M; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Mate R; Division of Analytical and Biological Science, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
  • Akello JO; Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
  • Huseynov S; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark.
  • Zeb A; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK.
  • Zambon M; National Polio Laboratory, Reference Services Division, UK Health Security Agency, London, UK.
  • Bell A; North East and North Central London Health Protection Team, UK Health Security Agency, London, UK.
  • Hagan J; World Health Organization Regional Office for Europe, Regional Polio Laboratory Network, Copenhagen, Denmark.
  • Wade MJ; Environmental Monitoring for Health Protection, Data, Analytics and Surveillance Group, UK Health Security Agency, Nobel House, London, UK.
  • Ramsay M; Immunisation and Vaccine Preventable Disease Division, UK Health Security Agency, London, UK.
  • Grassly NC; Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
  • Saliba V; Immunisation and Vaccine Preventable Disease Division, UK Health Security Agency, London, UK.
  • Martin J; Division of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK. Electronic address: javier.martin@nibsc.org.
Lancet ; 400(10362): 1531-1538, 2022 10 29.
Article en En | MEDLINE | ID: mdl-36243024
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poliomielitis / Poliovirus Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poliomielitis / Poliovirus Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido